Breast cancer (2).

[1]  A. Luini,et al.  Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. , 1990, European journal of cancer.

[2]  P. Rosen,et al.  The clinical significance of pre‐invasive breast carcinoma , 1980, Cancer.

[3]  S. Feig,et al.  Staging and treatment of clinically occult breast cancer , 1984, Cancer.

[4]  B. Gusterson,et al.  Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone. , 1990, British Journal of Cancer.

[5]  W. McGuire.  The optimal timing of mastectomy: low tide or high tide? , 1991, Annals of Internal Medicine.

[6]  R. Senie,et al.  Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. , 1991, Annals of internal medicine.

[7]  C. Bodian,et al.  Lobular neoplasia (so‐called lobular carcinoma in situ) of the breast , 1978, Cancer.

[8]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[9]  C Radovan,et al.  Breast Reconstruction after Mastectomy Using the Temporary Expander , 1982, Plastic and reconstructive surgery.

[10]  C. Redmond,et al.  Conservative management of intraductal carcinoma (DCIS) of the breast , 1991, Journal of surgical oncology.

[11]  J. Vilcoq,et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.

[12]  S. Paik,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS) , 1986, Cancer.

[13]  R. Clark,et al.  Breast Cancer Experiences with Conservation Therapy , 1987, American journal of clinical oncology.

[14]  A. Luini,et al.  Quadrantectomy versus lumpectomy for small size breast cancer. , 1990, European journal of cancer.

[15]  R. Goldwyn.  Breast reconstruction after mastectomy. , 1987, The New England journal of medicine.

[16]  S. Gruber,et al.  MENSTRUAL INFLUENCE ON SURGICAL CURE OF BREAST CANCER , 1989, The Lancet.

[17]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[18]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[19]  R. Arriagada,et al.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  J. Wheeler,et al.  Lobular carcinoma in situ of the breast(Long‐term followup , 1974, Cancer.

[21]  J. Hendriks,et al.  Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.

[22]  S. Feig,et al.  Heterogeneity of intraductai carcinoma of the breast , 1989 .

[23]  M. Lagios,et al.  Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short‐term treatment failures , 1982 .

[24]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[25]  M. Angell.  Breast implants--protection or paternalism? , 1992, The New England journal of medicine.

[26]  J. Bártková,et al.  Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. , 1990, Human pathology.

[27]  D. Schultz,et al.  The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. , 1991, International journal of radiation oncology, biology, physics.

[28]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[29]  J. Rosai,et al.  Borderline Epithelial Lesions of the Breast , 1991, The American journal of surgical pathology.

[30]  S J Schnitt,et al.  The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. , 1991, Annals of surgery.

[31]  M. Lagios,et al.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence , 1989, Cancer.

[32]  C. Alpers,et al.  The prevalence of carcinoma in situ in normal and cancer-associated breasts. , 1985, Human pathology.

[33]  I. Fentiman,et al.  Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer , 1991, The Lancet.

[34]  R. Sothern,et al.  Estrous influence on surgical cure of a mouse breast cancer , 1988, The Journal of experimental medicine.

[35]  A. Luini,et al.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.

[36]  W. Dupont,et al.  Intraductal carcinoma of the breast: Follow‐up after biopsy only , 1982, Cancer.

[37]  D. Carter.  Margins of "lumpectomy" for breast cancer. , 1986, Human pathology.

[38]  D A Kessler,et al.  The basis of the FDA's decision on breast implants. , 1992, The New England journal of medicine.

[39]  G F ROBBINS,et al.  Bilateral primary breast cancers. A prospective clinicopathological study , 1964 .

[40]  W. Dupont,et al.  Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. , 1991, Human pathology.

[41]  H. Kooy,et al.  Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  C. Jacquillat,et al.  Results of neoadjuvant chemotherapy and radiation therapy in the breast‐conserving treatment of 250 patients with all stages of infiltrative breast cancer , 1990, Cancer.

[43]  J. Fisher,et al.  The silicone controversy--when will science prevail? , 1992, The New England journal of medicine.

[44]  C. Redmond,et al.  Significance of ipsilateral breast tumour recurrence after lumpectomy , 1991, The Lancet.

[45]  D. Schultz,et al.  Ten‐year results of breast‐conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast , 1991, Cancer.

[46]  C. Key,et al.  Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.

[47]  M. Silverstein,et al.  Evaluation of Treatment Options for Ductal Carcinoma In Situ of the Breast-Reply , 1991 .

[48]  C. Kosloff,et al.  Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow‐up of 24 years , 1978, The American journal of surgical pathology.